ARIPIPRAZOLE 1 MG/ML SOLUTION
For 150 mL
Pharmacies pay
$49.68 filed
150 × $0.33119 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$62.13 estimated
$49.68 + $7.45 (15%) + $5.00 fee per fill = $62.13
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ARIPIPRAZOLE 1 MG/ML SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “aripiprazole” and “aripiprazole oral”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as solution and its route as oral.
FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Camber Pharmaceuticals, Inc., Lannett Company, Inc. and Apotex Corp.
FDA’s Established Pharmacologic Class for it is Atypical Antipsychotic.
The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $49.68 for 150 mL (150 × $0.33119 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The 7 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Advagen Pharma Ltd | 1 | $0.33119 per ML filed |
| Amneal Pharmaceuticals LLC | 1 | $0.33119 per ML filed |
| Apotex Corp. | 1 | $0.33119 per ML filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.33119 per ML filed |
| Lannett Company, Inc. | 1 | $0.33119 per ML filed |
| NorthStar RxLLC | 1 | $0.33119 per ML filed |
| VistaPharm, LLC | 1 | $0.33119 per ML filed |
All 7 NDCs, with labeler and price
- 31722-0684-15 · Camber Pharmaceuticals, Inc. · $0.33119 per ML · eff. 2026-09-23 filed
- 54838-0570-59 · Lannett Company, Inc. · $0.33119 per ML · eff. 2026-09-23 filed
- 60505-0404-05 · Apotex Corp. · $0.33119 per ML · eff. 2026-09-23 filed
- 65162-0893-74 · Amneal Pharmaceuticals LLC · $0.33119 per ML · eff. 2026-09-23 filed
- 66689-0735-05 · VistaPharm, LLC · $0.33119 per ML · eff. 2026-09-23 filed
- 72603-0445-01 · NorthStar RxLLC · $0.33119 per ML · eff. 2026-09-23 filed
- 72888-0100-20 · Advagen Pharma Ltd · $0.33119 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
20 other products in the NADAC file share an FDA nonproprietary name with ARIPIPRAZOLE 1 MG/ML SOLUTION.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ABILIFY 2 MG TABLET | $18.65546 per EA filed | $22.52657 per EA filed |
| ABILIFY 5 MG TABLET | $18.6836 per EA filed | $22.52657 per EA filed |
| ABILIFY 10 MG TABLET | $18.61552 per EA filed | $22.52657 per EA filed |
| ABILIFY 15 MG TABLET | $18.65186 per EA filed | $22.52657 per EA filed |
| ABILIFY 20 MG TABLET | $26.25042 per EA filed | $22.52657 per EA filed |
| ABILIFY 30 MG TABLET | $26.23171 per EA filed | $22.52657 per EA filed |
| ABILIFY ASIMTUFII 720 MG/2.4 ML | $1,785.22689 per ML filed | $1,764.23642 per ML filed |
| ABILIFY ASIMTUFII 960 MG/3.2 ML | $1,782.92743 per ML filed | $1,764.23642 per ML filed |
| ABILIFY MAINTENA ER 300 MG SYR | $2,139.08683 per EA filed | $2,236.80 per EA derived |
| ABILIFY MAINTENA ER 300 MG VL | $2,141.14811 per EA filed | $2,236.80 per EA derived |
| ABILIFY MAINTENA ER 400 MG SYR | $2,853.24574 per EA filed | $2,982.40 per EA derived |
| ABILIFY MAINTENA ER 400 MG VL | $2,857.76593 per EA filed | $2,982.40 per EA derived |
| ARIPIPRAZOLE 1 MG/ML SOLUTION this page | $0.33119 per ML filed | We don’t know yet |
| ARIPIPRAZOLE 2 MG TABLET | $0.11462 per EA filed | $1.54994 per EA filed |
| ARIPIPRAZOLE 5 MG TABLET | $0.10973 per EA filed | $1.54994 per EA filed |
| ARIPIPRAZOLE 10 MG TABLET | $0.11173 per EA filed | $1.54994 per EA filed |
| ARIPIPRAZOLE 15 MG TABLET | $0.13123 per EA filed | $1.54994 per EA filed |
| ARIPIPRAZOLE 20 MG TABLET | $0.17429 per EA filed | $1.54994 per EA filed |
| ARIPIPRAZOLE 30 MG TABLET | $0.17347 per EA filed | $1.54994 per EA filed |
| ARIPIPRAZOLE ODT 10 MG TABLET | $2.47005 per EA filed | $15.55143 per EA filed |
| ARIPIPRAZOLE ODT 15 MG TABLET | $2.22394 per EA filed | $15.55143 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 7 NDCs’ NADAC prices is $0.33119 per ML filed.
Of the 25 other products in FDA’s Atypical Antipsychotic class priced per ML, 25 have a higher middle NADAC price and 0 a lower one. The one in the middle is INVEGA SUSTENNA 39 MG/0.25 ML, at $2,338.748 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 150 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 150 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 150 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 150 mL in one package for all 7 NDCs of this product (“1 BOTTLE in 1 CARTON (31722-684-15) / 150 mL in 1 BOTTLE”), so the card starts at one package: 150 ML. Change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- QUETIAPINE 150 MG TABLET
- OLANZAPINE 10 MG TABLET
- CLOZAPINE 100 MG TABLET
- LURASIDONE HCL 120 MG TABLET
- VRAYLAR 0.5 MG CAPSULE